Patient Voice Impacts Treatment Experience
Source: IQVIA Technologies
In oncology trials, regulators want to see more than just test results and survival metrics. While clinical indications such as tumor size, delayed disease progression, and absence of side effects are excellent measures of a treatment's impact, they don't describe the patient's experience with the treatment. That lack of perspective can impact whether a treatment is approved, covered and prescribed. Download this guide for 5 key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader